Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
iShares MSCI Singapore ETF
EWS
$1.06B
| $1.46M | ﹤0.01% |
78,878
+78,735
| +55,059% | +$1.53M |
|
2027
ESCO Technologies
ESE
$8.5B
| $1.46M | ﹤0.01% |
14,083
+749
| +6% | +$72K |
|
2028
Privia Health
PRVA
$2.77B
| $1.46M | ﹤0.01% |
55,889
-981
| -2% | -$25.9K |
|
2029
Marqeta
MQ
$1.74B
| $1.46M | ﹤0.01% |
74,877
-12,595
| -14% | -$228K |
|
2030
Enpro
NPO
$7.12B
| $1.46M | ﹤0.01% |
10,917
-60
| -0.5% | -$6.37K |
|
2031
Jack in the Box
JACK
$331M
| $1.46M | ﹤0.01% |
14,946
+4,223
| +39% | +$384K |
|
|
DOOR
2032
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.45M | ﹤0.01% |
14,155
-2,900
| -17% | -$272K |
|
2033
AeroVironment
AVAV
$8.66B
| $1.45M | ﹤0.01% |
14,151
+1,554
| +12% | +$156K |
|
2034
Stock Yards Bancorp
SYBT
$2.61B
| $1.44M | ﹤0.01% |
31,749
+13,576
| +75% | +$636K |
|
2035
CareDx
CDNA
$2.32B
| $1.44M | ﹤0.01% |
169,018
+7,366
| +5% | +$61.4K |
|
2036
Benchmark Electronics
BHE
$2.96B
| $1.43M | ﹤0.01% |
55,486
-3,132
| -5% | -$72.4K |
|
2037
Piper Sandler
PIPR
$5.02B
| $1.43M | ﹤0.01% |
44,256
-1,172
| -3% | -$38.7K |
|
|
LADR
2038
Ladder Capital
LADR
$1.21B
| $1.43M | ﹤0.01% |
131,499
-16,619
| -11% | -$161K |
|
2039
PetMed Express
PETS
$42.1M
| $1.43M | ﹤0.01% |
103,456
+53,131
| +106% | +$798K |
|
2040
Lufax Holding
LU
$1.29B
| $1.42M | ﹤0.01% |
248,697
-185,348
| -43% | -$1.23M |
|
2041
Korn Ferry
KFY
$4.2B
| $1.42M | ﹤0.01% |
28,650
-2,654
| -8% | -$131K |
|
2042
Carpenter Technology
CRS
$27.7B
| $1.42M | ﹤0.01% |
25,246
-1,559
| -6% | -$76.3K |
|
2043
Apogee Enterprises
APOG
$900M
| $1.41M | ﹤0.01% |
29,696
-7,312
| -20% | -$305K |
|
2044
Recursion Pharmaceuticals
RXRX
$1.69B
| $1.41M | ﹤0.01% |
188,668
+446
| +0.2% | +$3.12K |
|
2045
Ingevity
NGVT
$2.66B
| $1.41M | ﹤0.01% |
24,226
-3,628
| -13% | -$218K |
|
2046
Monarch Casino & Resort
MCRI
$2.19B
| $1.41M | ﹤0.01% |
19,977
-5,405
| -21% | -$377K |
|
2047
JELD-WEN Holding
JELD
$154M
| $1.41M | ﹤0.01% |
80,168
-10,460
| -12% | -$146K |
|
2048
Ecovyst
ECVT
$1.2B
| $1.41M | ﹤0.01% |
122,626
+76,193
| +164% | +$829K |
|
|
SAFE
2049
Safehold
SAFE
$1.13B
| $1.4M | ﹤0.01% |
59,062
+45,307
| +329% | +$1.2M |
|
2050
Tower Semiconductor
TSEM
$25.4B
| $1.4M | ﹤0.01% |
37,322
+14,519
| +64% | +$600K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.